ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsAndrew J. Souers, Steven W. Elmore, Joel D. Leverson et al.|Nature Medicine|2013Cited by 3k
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-x <sub>L</sub> , but not Bcl-2, until displaced by BH3-only proteinsSimon N. Willis, David C.S. Huang|Genes & Development|2005Cited by 1.2k
Bim: a novel member of the Bcl‐2 family that promotes apoptosisLiam O’Connor, David C.S. Huang|The EMBO Journal|1998Cited by 1.2k
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapyJoel D. Leverson, Andrew J. Souers, John Xue et al.|Science Translational Medicine|2015Cited by 541
The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanismMary Ann Anderson, Andrew W. Roberts, Jing Deng et al.|Blood|2016Cited by 329